Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-017006

Options or other derivatives

  • Co-CEO acquired 926,640 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Chintu Co-CEO 2021-03-01 Grant or award · Performance-Based Restricted Stock Units +926,640 926,640 D
Loading xslF345X03/doc4.xml…